iRhythm Technologies (IRTC) Competitors $176.84 -0.53 (-0.30%) Closing price 10/14/2025 04:00 PM EasternExtended Trading$179.29 +2.45 (+1.38%) As of 10/14/2025 05:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. ZBH, SNN, SOLV, PEN, STVN, BLCO, GKOS, TMDX, SLNO, and NVSTShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and Envista (NVST). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Its Competitors Zimmer Biomet Smith & Nephew SNATS Solventum Penumbra Stevanato Group Bausch + Lomb Glaukos TransMedics Group Soleno Therapeutics Envista iRhythm Technologies (NASDAQ:IRTC) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, valuation, earnings, risk and dividends. Does the media refer more to IRTC or ZBH? In the previous week, Zimmer Biomet had 9 more articles in the media than iRhythm Technologies. MarketBeat recorded 24 mentions for Zimmer Biomet and 15 mentions for iRhythm Technologies. Zimmer Biomet's average media sentiment score of 0.72 beat iRhythm Technologies' score of 0.45 indicating that Zimmer Biomet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 3 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Zimmer Biomet 12 Very Positive mention(s) 2 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in IRTC or ZBH? 88.9% of Zimmer Biomet shares are held by institutional investors. 0.7% of iRhythm Technologies shares are held by company insiders. Comparatively, 0.7% of Zimmer Biomet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, IRTC or ZBH? iRhythm Technologies has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Do analysts rate IRTC or ZBH? iRhythm Technologies currently has a consensus price target of $180.23, indicating a potential upside of 1.92%. Zimmer Biomet has a consensus price target of $111.94, indicating a potential upside of 13.83%. Given Zimmer Biomet's higher possible upside, analysts plainly believe Zimmer Biomet is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 1 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.80Zimmer Biomet 2 Sell rating(s) 8 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.45 Which has better valuation & earnings, IRTC or ZBH? Zimmer Biomet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$591.84M9.60-$113.29M-$2.93-60.35Zimmer Biomet$7.68B2.54$903.70M$4.1123.93 Is IRTC or ZBH more profitable? Zimmer Biomet has a net margin of 10.51% compared to iRhythm Technologies' net margin of -14.06%. Zimmer Biomet's return on equity of 12.76% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-14.06% -90.03% -8.52% Zimmer Biomet 10.51%12.76%7.21% SummaryZimmer Biomet beats iRhythm Technologies on 12 of the 16 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.70B$2.25B$6.04B$10.50BDividend YieldN/AN/A5.73%4.80%P/E Ratio-60.3538.1184.3627.24Price / Sales9.6044.79502.46196.48Price / CashN/A61.6637.5761.53Price / Book60.9812.5512.356.74Net Income-$113.29M-$64.36M$3.32B$276.59M7 Day Performance-1.21%-2.44%-1.35%-0.47%1 Month Performance0.39%10.27%8.12%7.47%1 Year Performance194.10%36.07%73.78%34.58% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.2803 of 5 stars$176.84-0.3%$180.23+1.9%+205.2%$5.70B$591.84M-60.352,000Analyst ForecastZBHZimmer Biomet4.7508 of 5 stars$94.79-2.6%$112.67+18.9%-6.2%$18.78B$7.83B23.0617,000Analyst ForecastSNNSmith & Nephew SNATS3.4854 of 5 stars$35.09-1.8%$36.00+2.6%+23.2%$15.28B$5.94B16.2417,349Analyst ForecastSOLVSolventum2.8916 of 5 stars$70.53-1.8%$84.89+20.4%+3.0%$12.23B$8.39B32.6522,000Positive NewsPENPenumbra4.5271 of 5 stars$260.96-0.2%$303.44+16.3%+20.8%$10.18B$1.19B69.404,500STVNStevanato GroupN/A€23.85-2.1%N/A+32.3%€7.22B€1.19B44.175,521BLCOBausch + Lomb1.5364 of 5 stars$14.35-0.5%$15.70+9.4%-27.4%$5.08B$4.79B-18.4013,500GKOSGlaukos4.3353 of 5 stars$82.55-5.1%$118.00+42.9%-34.5%$4.73B$383.48M-50.03780Analyst ForecastTMDXTransMedics Group3.366 of 5 stars$107.29-5.0%$125.40+16.9%-17.1%$3.66B$531.29M55.59210News CoverageAnalyst ForecastGap DownSLNOSoleno Therapeutics4.3891 of 5 stars$63.76-2.7%$115.92+81.8%+18.0%$3.39B$32.66M-15.4030NVSTEnvista4.0477 of 5 stars$19.10-5.4%$21.08+10.4%+9.0%$3.17B$2.55B59.6912,300Analyst Revision Related Companies and Tools Related Companies Zimmer Biomet Alternatives Smith & Nephew SNATS Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Bausch + Lomb Alternatives Glaukos Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
